To Study the Clinical Course and Outcomes of Non-electively Hospitalised Patients of Chronic Liver Disease (CLD) With Hepatic or Extra-hepatic Predominant Organ Failure(s) at 6 Months.
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Death or liver transplant at 6 months follow up.
研究概览
简要总结
Title - To study the clinical course and outcomes of non-electively hospitalised patients of chronic liver disease (CLD) with Hepatic or Extra-hepatic predominant organ failure(s) at 6 months.
Summary - ACLF is a condition where acute insult leading to worsening liver failure with or without extra-hepatic failure leads to a high short-term mortality. However, the presence of cirrhosis, prior decompensation, non-hepatic/systemic acute insult, organ failure and treatment are different in different part of the world. This is due to in-homogenous patient cohort. The current study was planned for all patients of CLD, who were non-electively hospitalized and were followed up for long-term to identify the differences in clinical course, acute insult, organ failure, therapy and outcome in relation to liver failure with or without extra-hepatic organic failure. In the study the laboratory, clinical parameters, inflammatory and regenerative markers will be evaluated as a marker of disease progression, reversal, recompensation or regression. This will enable us to differentiate the ACLF between east and west, guide us for defining the natural course of CLD with failure.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 70 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 18-70 years
- •CLD with or without cirrhosis with 1st or subsequent admissions for decompenasation and irrespective of any prior decompensation
- •Non-electively hospitalized
排除标准
- •Post-Liver transplant
研究组 & 干预措施
Chronic Liver Disease (CLD) With Hepatic Predominant Organ Failure
干预措施: No Intervention (Other)
Chronic Liver Disease (CLD) With Extra-hepatic Predominant Organ Failure
干预措施: No Intervention (Other)
结局指标
主要结局
Death or liver transplant at 6 months follow up.
时间窗: 6 months
次要结局
- Recovery as per disease severity scores, i.e- decrease in MELD ≥5 and CTP ≥3(6 months)
- Organ dysfunction and organ failures(day 28, day 90, day 180)
